Nektar Therapeutics to discuss alopecia areata trial results
Nektar Therapeutics (NASDAQ: NKTR) will host a conference call on April 20, 2026 at 8:00 a.m. ET to present 52-week ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
